Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

Following work by our science team, including two influential papers on the need for improvements (published on ALTEX and the ...

The UK Home Office is taking a significant step towards higher quality and more transparent project licence applications ...

After hours: March 12 at 7:59:25 PM EDT Loading Chart for ICON ...